Biocontrol Technology (BICO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocontrol Technology (BICO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: marydon2 who wrote ()	5/24/1999 10:35:00 AM
From: Egolpi	of 26

(OTC BB:BICO) B: Biocontrol Submits Module for Diasensor to FDA B: Biocontrol Submits Module for Diasensor to FDA PITTSBURGH (May 24) BUSINESS WIRE -May 24, 1999--Biocontrol Technology Inc. (OTC BB:BICO) announced today that the first module of its modular premarket approval application (PMA) submission for the Diasensor 2000 was submitted to the FDA. This module contains a description of Biocontrol Technology's manufacturing methods, facilities and controls, including design controls as required by FDA regulations. The FDA approved Biocontrol's PMA Shell submission in mid-April of this year. The Diasensor 2000 noninvasive glucose monitor is similar to the Diasensor 1000 model with enhancements to the operating software and hardware. Biocontrol Technology has its corporate offices in Pittsburgh, and is involved in the development and manufacture of biomedical devices and environmental products. Biocontrol has the exclusive rights to the research and development and manufacturing of the Diasensor 2000. Subsidiary Diasensor.com Inc., also located in Pittsburgh, owns the patent, marketing and distribution rights to the sensor. WEB SITE: www.bico.com INVESTOR RELATIONS NEWSLINE NUMBER: 800/357-6204

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next